Targeted gene delivery in the cricket brain, using in vivo electroporation

被引:3
|
作者
Matsumoto, Chihiro Sato [1 ]
Shidara, Hisashi [2 ]
Matsuda, Koji [3 ]
Nakamura, Taro [3 ]
Mito, Taro [3 ]
Matsumoto, Yukihisa [1 ]
Oka, Kotaro [2 ]
Ogawa, Hiroto [1 ,4 ]
机构
[1] Hokkaido Univ, Fac Sci, Dept Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan
[2] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan
[3] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan
[4] JST, PREST, Saitama 3320012, Japan
关键词
Insect; Cricket; Brain; Electroporation; Neuron; Green fluorescent protein; CA2+ DYNAMICS; PATTERNS; EXPRESSION; BEHAVIOR; EMBRYOS; SYSTEM;
D O I
10.1016/j.jinsphys.2013.10.001
中图分类号
Q96 [昆虫学];
学科分类号
摘要
The cricket (Gryllus bimaculatus) is a hemimetabolous insect that is emerging as a model organism for the study of neural and molecular mechanisms of behavioral traits. However, research strategies have been limited by a lack of genetic manipulation techniques that target the nervous system of the cricket. The development of a new method for efficient gene delivery into cricket brains, using in vivo electroporation, is described here. Plasmid DNA, which contained an enhanced green fluorescent protein (eGFP) gene, under the control of a G. bimaculatus actin (Gb'-act) promoter, was injected into adult cricket brains. Injection was followed by electroporation at a sufficient voltage. Expression of eGFP was observed within the brain tissue. Localized gene expression, targeted to specific regions of the brain, was also achieved using a combination of local DNA injection and fine arrangement of the electroporation electrodes. Further studies using this technique will lead to a better understanding of the neural and molecular mechanisms that underlie cricket behaviors. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1235 / 1241
页数:7
相关论文
共 50 条
  • [21] In vivo targeted gene delivery through FGF receptors
    Aukerman, SL
    Gu, D
    Sosnowski, B
    Gonzalez, AM
    Hoganson, DK
    Chandler, LA
    DAndrea, M
    Baird, A
    Pierce, GF
    CANCER GENE THERAPY, 1997, 4 (06) : O44 - O44
  • [22] Developing Lentiviral Vectors for Targeted Gene Delivery In Vivo
    Ou, Wu
    Suzuki, Akiko
    Marino, Michael P.
    Li, Pingjuan
    Joshi, Bharat
    Husain, Syred R.
    Puri, Raj K.
    Reiser, Jakob
    MOLECULAR THERAPY, 2014, 22 : S23 - S23
  • [23] Gene Delivery to Skin by Electroporation
    Gothelf, Anita
    MOLECULAR THERAPY, 2012, 20 : S239 - S239
  • [24] In-vivo gene transfer into newly hatched chick brain by electroporation
    Yamaguchi, Shinji
    Katagiri, Sachiko
    Hirose, Naoki
    Fujimoto, Yasuyuki
    Mori, Masahiro
    Fujii-Taira, Ikuko
    Takano, Tatsuya
    Matsushima, Toshiya
    Homma, Koichi J.
    NEUROREPORT, 2007, 18 (08) : 735 - 739
  • [25] Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
    Sepasi, Tina
    Bani, Farhad
    Rahbarghazi, Reza
    Ebrahimi-Kalan, Abbas
    Sadeghi, Mohammad-Reza
    Alamolhoda, Seyedeh Zahra
    Zarebkohan, Amir
    Ghadiri, Tahereh
    Gao, Huile
    BIOIMPACTS, 2023, 13 (02) : 133 - 144
  • [26] Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo
    Wells, Dominic J.
    CELL BIOLOGY AND TOXICOLOGY, 2010, 26 (01) : 21 - 28
  • [27] In vivo electroporation for gene therapy
    Heller, Loree C.
    Heller, Richard
    HUMAN GENE THERAPY, 2006, 17 (09) : 890 - 897
  • [28] Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo
    Dominic J. Wells
    Cell Biology and Toxicology, 2010, 26 : 21 - 28
  • [29] An Electroporation System for Targeted Cellular Drug Delivery
    Klag, Emily L.
    English, Anthony E.
    2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC), 2015,
  • [30] In vivo-targeted gene delivery using antibody-based nonviral vector
    Déas, O
    Angevin, E
    Cherbonnier, C
    Senik, A
    Charpentier, B
    Levillain, JP
    Oosterwijk, E
    Hirsch, F
    Dürrbach, A
    HUMAN GENE THERAPY, 2002, 13 (09) : 1101 - 1114